Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease. Rossato P, Federti E, Matte A, Glantschnig H, et al. Haematologica 2022;107:2650-2660.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rossato P, Federti E, Matte A, Glantschnig H, et al. Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease. Haematologica 2022;107:2650-2660.
PMID: 35443560